The latest news video from Andrew Schorr and Patient Power from the 9th European Congress on Hematologic Malignancies in Lyon, France: Is with Dr Susan O’Brian as she shares her views on B-cell receptor Agents. The inhibitors much discussed in earlier broadcasts from over the pond at ASH.
"What are B-cell receptor agents? How can they help in chronic lymphocytic leukemia (CLL) treatment? There are several new drugs, B-cell receptor agents, now in clinical trials. Could they be the start of a new age in the treatment of CLL?"
patientpower.info/video/b-c...
I hope Andrew Schorr was able to capture interviews with the Leading UK/European CLL speakers too.Will keep my eyes peeled.
Session III: Chronic Lymphocytic Leukemia I
Moderator: Eva Kimby, MD, PhD
9:05 Genomic abnormalities in CLL
Anna Schuh, MD, PhD
9:25 Optimal frontline management of CLL patients
Susan O’Brien, MD
9:45 Optimal frontline therapy for the high risk patient (17p deletion)
Peter Hillmen, MD
10:05 What is the role of transplantation today in CLL? Peter Dreger, MD
Session IV: Chronic Lymphocytic Leukemia II
Moderator: Susan O’Brien, MD
11:00 Treatment of the elderly patient with CLL
Barbara Eichhorst, MD
11:20 Management of the relapsed/refractory patient
Claire Dearden, MD
11:40 BTK inhibition in CLL
Susan O’Brien, MD
imedex.com/hematologic-mali...
Happy Easter